Advisor HD Grid Observational Study

CompletedOBSERVATIONAL
Enrollment

379

Participants

Timeline

Start Date

January 11, 2019

Primary Completion Date

May 27, 2021

Study Completion Date

May 27, 2021

Conditions
Persistent Atrial FibrillationVentricular Tachycardia
Interventions
DEVICE

Advisor HD Grid Mapping Catheter, Sensor Enabled

The Advisor™ HD Grid Mapping Catheter, Sensor Enabled™, is indicated for multiple electrode electrophysiological mapping of cardiac structures in the heart, i.e., recording or stimulation only. This catheter is intended to obtain electrograms in the atrial and ventricular regions of the heart.

Trial Locations (25)

1397

Herzzentrum Dresden GmbH Universitätsklinik, Dresden

1411

Ospedale Cardinal Massaia Di Asti, Asti

2066

The Alfred Hospital, Melbourne

2700

KH Wiener Neustadt, Wiener Neustadt

3168

Monash Medical Centre, Clayton

4020

A. ö. Krankenhaus der Elisabethinen Linz, Linz

4032

The Prince Charles Hospital, Chermside

4289

Herzzentrum Leipzig GmbH, Leipzig

5042

Flinders Private Hospital, Bedford Park

8001

Christiaan Barnard Memorial Hospital, Cape Town

8036

Hospital Universitario Marqués de Valdecilla, Santander

Hospital Clinic I Provincial de Barcelona, Barcelona

8200

Skejby University Hospital, Aarhus

20132

Ospedale San Raffaele, Milan

20246

UKE Hamburg (Universitatsklinik Eppendorf), Hamburg

63050

Pole Sante Republique, Clermont-Ferrand

67200

Clinique Rhena, Strasbourg

91300

Institute Cardio. Paris-Sud - Institut Jacques Cartier, Massy

V6E1M7

St. Paul's Hospital, Vancouver

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

G1V 4G5

Institut de Cardiologie de Quebec (Hôpital Laval), Québec

Unknown

Klinikum Fürth, Fürth

Medizinische Einrichtungen der Universität zu Köln, Cologne

2545AA

Haga Ziekenhuis Locatie Leyenburg, The Hague

1070-313

Santa Maria Hospital, Lisbon

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY

NCT03733392 - Advisor HD Grid Observational Study | Biotech Hunter | Biotech Hunter